Elhawary Esraa Elsayed, Abdelnaby Naeim Mohamed, Rezk Ghada Fawzy, Qandil Asmaa Mohamed
Dermatology, Venereology and Andrology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Lasers Surg Med. 2025 Feb;57(2):154-162. doi: 10.1002/lsm.23876. Epub 2025 Jan 9.
Alopecia areata (AA) is a chronic inflammatory disease that affects the hair follicles and sometimes the nails. It usually presents as a single or multiple patches of hair loss on the scalp, but any hair-bearing skin can be involved. AA treatment depends on the severity and extent of the disease.
To evaluate the efficacy of combined fractional CO (FCO) laser with topical minoxidil 5% solution versus topical minoxidil 5% solution alone in the treatment of AA.
The study included 150 patients with AA. The patients were collected from outpatient clinics of the Dermatology and Venerology Department, Tanta University Hospitals. Patients were divided into three groups; 60 patients were treated with topical minoxidil 5% solution, 60 patients were treated with FCO laser combined with topical minoxidil 5% solution, and the third group of 30 patients represented the control group treated with topical saline.
Compared to the placebo group, there was a statistically significant improvement in hair growth in the combination group and minoxidil group. In the combination group, 80% of patients showed excellent improvement, 13.3% of patients showed very good improvement, and 6.7% of patients showed good improvement. In the minoxidil group, 53% of patients showed excellent improvement, 40% of patients showed very good improvement, and 6.7% of patients showed good improvement after 3 months of therapy. Side effects were minimal and transient in both groups.
Topical minoxidil 5% solution either alone or in combination with FCO laser could be considered a safe and tolerable method for AA treatment.
斑秃(AA)是一种影响毛囊,有时也会影响指甲的慢性炎症性疾病。它通常表现为头皮上单个或多个脱发斑,但任何有毛发的皮肤都可能受累。AA的治疗取决于疾病的严重程度和范围。
评估联合分次二氧化碳(FCO)激光与5%外用米诺地尔溶液相比,单独使用5%外用米诺地尔溶液治疗AA的疗效。
该研究纳入了150例AA患者。这些患者来自坦塔大学医院皮肤科和性病科门诊。患者分为三组;60例患者接受5%外用米诺地尔溶液治疗,60例患者接受FCO激光联合5%外用米诺地尔溶液治疗,第三组30例患者为对照组,接受外用生理盐水治疗。
与安慰剂组相比,联合组和米诺地尔组的毛发生长有统计学显著改善。联合组中,80%的患者显示出极佳改善,13.3%的患者显示出非常好的改善,6.7%的患者显示出良好改善。在米诺地尔组中,治疗3个月后,53%的患者显示出极佳改善,40%的患者显示出非常好的改善,6.7%的患者显示出良好改善。两组的副作用均轻微且短暂。
单独使用或与FCO激光联合使用5%外用米诺地尔溶液可被认为是一种治疗AA的安全且可耐受的方法。